United States: MPI Research, the largest single-site preclinical contract research organization worldwide, pleased to announce that Dale M. Cooper, DVM, recently joined MPI Research as its Director of Clinical Medicine. Dr. Cooper will oversee animal care for the company’s three core research divisions: Drug Safety Evaluation, Discovery Services, and Bioanalytical/Analytical Services.

Dr. Cooper, a Diplomate of the American College of Laboratory Animal Medicine, brings a broad scope of veterinary clinical medical experience to MPI Research. Most recently, he was the Director of Laboratory Animal Medicine, Quality, and Technical Services for North America for Harlan Laboratories, Inc. Prior to that, he was a Principal Research Scientist with Eli Lilly. Dr. Cooper also has experience in consulting and community veterinary medicine as well as academia. He received his DVM from the University of Wisconsin, Madison and is widely published in the animal husbandry literature.

Dr. Tina Rogers, PhD, MBA, DABT, Director of Research and Executive Vice President at MPI Research, states, “Dr. Cooper has a proven track record of ensuring the highest possible standards of animal welfare. Our company is known for its commitment to conducting studies in an ethical and humane way, and with Dr. Cooper at the helm of our animal care program, this commitment is strengthened even further.”

MPI Research, with global headquarters in Mattawan, Michigan, provides safety evaluation, discovery, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world. Learn more about how we can exceed your expectations at www.mpiresearch.com.